Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
23.43
-0.16 (-0.68%)
At close: Nov 26, 2025, 4:00 PM EST
23.40
-0.03 (-0.13%)
After-hours: Nov 26, 2025, 7:57 PM EST
Catalyst Pharmaceuticals Revenue
Catalyst Pharmaceuticals had revenue of $148.39M in the quarter ending September 30, 2025, with 15.31% growth. This brings the company's revenue in the last twelve months to $578.20M, up 25.56% year-over-year. In the year 2024, Catalyst Pharmaceuticals had annual revenue of $491.73M with 23.49% growth.
Revenue (ttm)
$578.20M
Revenue Growth
+25.56%
P/S Ratio
4.93
Revenue / Employee
$3,194,453
Employees
181
Market Cap
2.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 491.73M | 93.53M | 23.49% |
| Dec 31, 2023 | 398.20M | 184.00M | 85.90% |
| Dec 31, 2022 | 214.20M | 73.37M | 52.10% |
| Dec 31, 2021 | 140.83M | 21.76M | 18.27% |
| Dec 31, 2020 | 119.07M | 16.77M | 16.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CPRX News
- 3 days ago - Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - GlobeNewsWire
- 8 days ago - Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™ - GlobeNewsWire
- 9 days ago - Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference - GlobeNewsWire
- 21 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 23 days ago - Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work - GlobeNewsWire
- 24 days ago - Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire